文献速递糖尿病肥胖与代谢综合征

新发早发型与晚发型2型糖尿病及早发型与晚发型癌症风险:前瞻性队列研究

Incident Early- and Later-Onset Type 2 Diabetes and Risk of Early- and Later-Onset Cancer: Prospective Cohort Study.
PubMed 文献 · Diabetes Care · 2023-01-01

研究前瞻性随访护士健康研究228,073名合格参与者最长38年,记录18,290例2型糖尿病、6,520例早发型癌症和36,907例晚发型癌症。早发型2型糖尿病与早发型总癌症、糖尿病相关癌症和肥胖相关癌症风险升高相关,且风险升高限于18岁时BMI≥21 kg/m2者;晚发型2型糖尿病与晚发型总癌症、糖尿病相关癌症和肥胖相关癌症风险升高相关。作者认为早发型2型糖尿病对癌症风险的影响可能本质上强于晚发型2型糖尿病。

要点

  • 早发型2型糖尿病与早发型总癌症风险升高相关(HR 1.47,95%CI 1.06-2.04)。
  • 早发型2型糖尿病的癌症风险升高限于18岁时BMI≥21 kg/m2者。
  • 晚发型2型糖尿病与晚发型总癌症风险升高相关(HR 1.15,95%CI 1.11-1.20)。

核心结论

  • 新发早发型2型糖尿病与早发型总癌症及糖尿病相关、肥胖相关癌症风险升高相关,尤其在18岁时BMI较高者中。
  • 作者认为早发型2型糖尿病对癌症风险的影响可能本质上强于晚发型2型糖尿病。

研究设计与样本

  • 前瞻性队列研究,随访护士健康研究228,073名合格参与者,最长38年。
  • 采用Cox模型估计风险比(HR)及95%CI。

主要发现

  • 随访期间记录18,290例2型糖尿病、6,520例早发型癌症和36,907例晚发型癌症。
  • 早发型2型糖尿病与早发型总癌症(HR 1.47,95%CI 1.06-2.04)、糖尿病相关癌症(HR 2.11,95%CI 1.38-3.23)和肥胖相关癌症(HR 1.75,95%CI 1.08-2.82)风险升高相关。
  • 上述风险升高限于18岁时BMI≥21 kg/m2者:总癌症HR 1.75(95%CI 1.20-2.56)、糖尿病相关癌症HR 2.43(95%CI 1.50-3.94)、肥胖相关癌症HR 1.84(95%CI 1.05-3.22)。
  • 早发型2型糖尿病与晚发型糖尿病相关癌症和肥胖相关癌症风险升高相关,仅见于18岁时BMI较高者。
  • 晚发型2型糖尿病与晚发型总癌症(HR 1.15,95%CI 1.11-1.20)、糖尿病相关癌症(HR 1.17,95%CI 1.12-1.22)和肥胖相关癌症(HR 1.18,95%CI 1.13-1.24)风险升高相关。

关键数值与推荐

  • 早发型2型糖尿病定义为40岁前诊断;早发型癌症定义为50岁前诊断。
  • 早发型2型糖尿病与早发型总癌症风险升高相关(HR 1.47,95%CI 1.06-2.04)。
  • 晚发型2型糖尿病与晚发型总癌症风险升高相关(HR 1.15,95%CI 1.11-1.20)。
  • 早发型2型糖尿病的癌症风险升高限于18岁时BMI≥21 kg/m2者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated prospectively the association between incident early-onset (diagnosed before 40 years of age) and later-onset type 2 diabetes and early-onset (diagnosed before 50 years of age) and later-onset cancer risk. RESEARCH DESIGN AND METHODS: We prospectively followed 228,073 eligible participants in the Nurses' Health Studies for up to 38 years. Hazard ratios (HRs) and 95% CI were estimated using Cox models. RESULTS: We documented 18,290 type 2 diabetes, 6,520 early-onset cancer, and 36,907 later-onset cancer cases during follow-up. In fully adjusted analyses, early-onset type 2 diabetes was associated with increased risk of early-onset total cancer (HR [95% CI] 1.47 [1.06-2.04]), diabetes-related cancer (2.11 [1.38-3.23]), and obesity-related cancer (1.75 [1.08-2.82]), and the risk elevations were restricted to those with a BMI at 18 years of age of ≥21 kg/m2 (total cancer: 1.75 [1.20-2.56]; diabetes-related cancer: 2.43 [1.50-3.94]; and obesity-related cancer: 1.84 [1.05-3.22]). Early-onset type 2 diabetes was associated with higher risk of later-onset diabetes-related and obesity-related cancer specifically among individuals with higher BMI at 18 years of age. Later-onset type 2 diabetes was associated with a higher risk of later-onset total cancer (1.15 [1.11-1.20]), diabetes-related cancer (1.17 [1.12-1.22]), and obesity-related cancer (1.18 [1.13-1.24]). In analyses based on refined timing, the HRs attenuated substantially with aging. CONCLUSIONS: Incident early-onset type 2 diabetes was associated with increased risk of early-onset total cancer and diabetes- and obesity-related cancer, especially in those with higher BMI at 18 years of age. The impact of early-onset type 2 diabetes on cancer risk may be inherently stronger than that of later-onset type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Song M, Cao Y, et al. Incident Early- and Later-Onset Type 2 Diabetes and Risk of Early- and Later-Onset Cancer: Prospective Cohort Study. Diabetes Care. 2023. PMID: 36399782. doi:10.2337/dc22-1575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。